Pharmaco - Press Releases

Date	Title	Company
13-Dec-2021	Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers	Akoya Biosciences
13-Dec-2021	Calquence reduced the risk of disease progression or death by 71% vs. standard of care combinations at three years in the ASCEND Phase III trial	AstraZeneca
13-Dec-2021	PFIZER AND SANGAMO ANNOUNCE UPDATED PHASE 1/2 RESULTS SHOWING SUSTAINED BLEEDING CONTROL IN HIGHEST DOSE COHORT THROUGH TWO YEARS FOLLOWING HEMOPHILIA A GENE THERAPY	PFIZER
13-Dec-2021	Novo Nordisk invests more than DKK 17 bn in expansion of the manufacturing facilities in Kalundborg, Denmark	Novo Nordisk
13-Dec-2021	DEFENCE THERAPEUTICS ACCUMTM BOOSTS BY 9-FOLD THE DELIVERY EFFECTIVENESS OF THE CRISPR/CAS9 PROTEIN TO TARGET CELLS	Defence Therapeutics Inc.
12-Dec-2021	MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis	MorphoSys AG
11-Dec-2021	MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi(R)) in Combination with Lenalidomide for the Treatment of r/r DLBCL	MorphoSys AG
10-Dec-2021	Novasep invests €6 million to further expand API production capacity on its Chasse-sur-Rhône site	Novasep
10-Dec-2021	Report demonstrates Stevenage Bioscience Catalyst’s key role in delivering the economic benefit from leading edge UK life sciences	Stevenage Bioscience Catalyst (SBC)
10-Dec-2021	Nanopharm Announces Expansion to Enable Full Services Solutions to Meet Increasing Customer Needs	Nanopharm Ltd
10-Dec-2021	New Data Presented at SABCS 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making	Exact Sciences Corp.
10-Dec-2021	Illumina Supports Norway’s Pioneering Precision Medicine Study	Illumina, Inc.
10-Dec-2021	Original-Research: HAEMATO AG (von GBC AG)	HAEMATO AG
10-Dec-2021	New Lilly Study Reveals Underappreciation of Bowel Urgency as a Symptom of Ulcerative Colitis and Highlights Communication Gap Between Healthcare Providers and Patients	Lilly
10-Dec-2021	New data from the phase II CITYSCAPE trial show encouraging results with Roche’s novel anti-TIGIT tiragolumab plus Tecentriq	Roche
10-Dec-2021	World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster	Johnson & Johnson
10-Dec-2021	VUITY™ (pilocarpine HCI ophthalmic solution) 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry Near Vision (Presbyopia), is Now Available	AbbVie
10-Dec-2021	FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue	Thermo Fisher Scientific
10-Dec-2021	aap launches world's first human clinical study for antibacterial silver coating technology on anatomical plates and screws for fracture treatment	aap Implantate AG
10-Dec-2021	Relief Reports that its U.S. Collaboration Partner has Agreed with Hungarian Health Officials on a Pathway for Aviptadil	RELIEF THERAPEUTICS Holding AG